Abbott Laboratories (ABT) vs Amgen Inc. (AMGN)
A side-by-side comparison of Abbott Laboratories and Amgen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
ABT
Abbott Laboratories
$107.32HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
AMGN
Amgen Inc.
$393.10HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ABT vs AMGN
growth of $100 · dividends reinvested · last 30yABT +1921.4%AMGN +3992.1%AMGN compounded faster
ABT AMGN
ABT vs AMGN: by the numbers
- •AMGN is the larger company ($212.16B vs $186.93B market cap).
- •AMGN trades at the lower trailing earnings multiple (26.18 vs 33.60 P/E), one valuation lens rather than an overall verdict.
- •AMGN converts more revenue to profit (20.95% vs 11.65% net margin).
- •AMGN grew revenue faster over the past five years (8.15% vs 2.98% CAGR).
- •AMGN pays the higher dividend yield (2.60% vs 2.34%).
Metrics side by side
Valuation
| Metric | ABT | AMGN |
|---|---|---|
| P/E ratio | 33.60 | 26.18 |
| Forward P/E | 18.96 | 16.84 |
| P/S ratio | 3.91 | 5.50 |
| P/B ratio | 3.51 | 22.27 |
| PEG ratio | 4.09 | 0.26 |
| EV / EBITDA | 21.21 | 14.99 |
| FCF yield | 4.04% | 4.20% |
Profitability
| Metric | ABT | AMGN |
|---|---|---|
| Gross margin | 56.80% | 71.46% |
| Operating margin | 17.03% | 31.63% |
| Net margin | 11.65% | 20.95% |
| ROE | 10.42% | 84.87% |
| ROIC | 8.43% | 13.16% |
Dividends
| Metric | ABT | AMGN |
|---|---|---|
| Dividend yield | 2.34% | 2.60% |
| Payout ratio | 65.24% | 68.39% |
Growth (annualized)
| Metric | ABT | AMGN |
|---|---|---|
| Revenue CAGR (5Y) | 2.98% | 8.15% |
| EPS CAGR (5Y) | 8.22% | 2.94% |
| FCF CAGR (5Y) | 5.26% | -2.66% |
| Total return CAGR (5Y) | -0.78% | 13.52% |
Frequently asked
- Which has the lower trailing P/E, ABT or AMGN?
- AMGN has the lower trailing P/E: ABT trades at 33.60 and AMGN at 26.18. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABT or AMGN?
- Over the past five years, AMGN grew revenue faster — ABT at a 2.98% CAGR versus AMGN at 8.15%.
- Does ABT or AMGN pay a bigger dividend?
- ABT yields 2.34% and AMGN yields 2.60% based on trailing dividends and the latest price.
- Is ABT or AMGN more profitable?
- AMGN runs the higher net margin — ABT at 11.65% versus AMGN at 20.95%.
- How have ABT and AMGN total returns compared?
- Over the past 10 years, ABT delivered 11.19% and AMGN delivered 11.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioAmgen P/E ratioAbbott Laboratories dividend yieldAmgen dividend yieldAbbott Laboratories ROEAmgen ROEAbbott Laboratories operating marginAmgen operating marginAbbott Laboratories revenue growthAmgen revenue growthAbbott Laboratories free cash flowAmgen free cash flow
Abbott Laboratories & Amgen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.